On this page · 9 sections

Leqembi (injection)

Generic name: lecanemab (injection)

Brand names: Leqembi

Last updated November 2, 2026 0 views
Share

What is lecanemab?

Lecanemab is used to treat adults with Alzheimer's disease.

Lecanemab may also be used for reasons not mentioned in this medication guide.

This section was rewritten for readability and reviewed for meaning.

Warnings

Lecanemab can cause temporary swelling or bleeding in the brain that usually goes away over time. This condition may not show any symptoms but can be serious. Call your doctor if you experience headaches, dizziness, nausea, confusion, difficulty walking, seizures, or changes in vision.

This section was rewritten for readability and reviewed for meaning.

Before taking this medicine

Lecanemab can cause a condition called Amyloid Related Imaging Abnormalities or "ARIA," which is temporary swelling or small spots of bleeding in the brain that usually goes away over time. Your doctor may perform an MRI of your brain before and during your treatment with lecanemab. Ask your doctor about your risk.

It is not known if lecanemab will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant.

Ask a doctor if it is safe to breastfeed while using this medicine.

This section was rewritten for readability and reviewed for meaning.

Lecanemab side effects

Get emergency medical help if you notice signs of an allergic reaction: hives; trouble breathing; swelling of your face, lips, tongue, or throat.

Some side effects may happen during the injection. Tell your medical caregiver if you feel dizzy, nauseous, light-headed, itchy, sweaty, or have a headache, flu-like symptoms, fever, or vomiting; chest tightness, fast or slow heartbeats, pounding heartbeats, back pain, trouble breathing, or swelling in your face.

Common side effects of Leqembi may include:

  • ARIA with symptoms or with signs that show up on an MRI;
  • infusion-related reactions; or
  • headache.

This is not a complete list of side effects, and others may happen. Call your doctor for medical advice about side effects. You can report side effects to the FDA at 1-800-FDA-1088.

This section was rewritten for readability and reviewed for meaning.

How is lecanemab given?

Lecanemab is injected into a vein by a healthcare provider.

This medicine is injected slowly over 1 hour every 2 weeks.

You may be given other medications to help prevent serious side effects or allergic reaction.

Store this medicine in the refrigerator in the original container, do not freeze or shake.

What happens if I miss a dose?

Call your doctor for guidance if you miss an appointment for your Leqembi (injection).

This section was rewritten for readability and reviewed for meaning.

What happens if I overdose?

In a medical setting, an overdose would be treated quickly.

Follow your doctor's instructions regarding any restrictions on food, drinks, or activities.

This section was rewritten for readability and reviewed for meaning.

What other drugs will affect lecanemab?

Tell your doctor about all the other medicines you are taking, especially those for treating or preventing blood clots, including aspirin.

Other drugs may influence how lecanemab works, including prescription and over-the-counter medicines, vitamins, and herbal products. Make sure to inform your doctor about all the other medicines you are using.

Find detailed information on biosimilars for this medication.

This section was rewritten for readability and reviewed for meaning.

Common questions about Leqembi

Who makes and manufactures Leqembi (lecanemab-irmb)?
Leqembi is manufactured by Eisai Inc. based in Nutley, NJ, USA. You can contact Eisai at 1-833-453-7362 (Monday–Friday, 8 AM–8 PM ET) or online at Eisai Patient Support.
What drugs can help improve or slow down memory loss?
Drugs used to improve or slow down memory include prescription medications (e.g., cholinesterase inhibitors like donepezil) and over-the-counter products like ginseng and nootropics. Continue reading
How do I decide between Leqembi and Kisunla?
Leqembi (lecanemab-irmb) and Kisunla (donanemab-azbt) are two injectable treatments for Alzheimer’s disease, a condition affecting more than 7 million people in the United States. Both drugs clear sticky beta-amyloid protein from the brain and modestly slow how fast the disease gets worse. Neither one cures Alzheimer’s or brings back lost memories. There is no single “better” drug — the right choice depends on your safety risk, your schedule, and your goals. Continue reading
What are Monoclonal Antibodies and how do they work?
Monoclonal antibodies (mAbs) are man-made proteins that mimic the natural antibodies produced by our immune systems. Monoclonal antibodies can be formulated into medicines to treat various types of illnesses, such as cancer, rheumatoid arthritis or psoriasis. Continue reading
What is the controversy surrounding Leqembi?
Leqembi (lecanemab-irmb), a medication designed to treat Alzheimer's disease, has been a subject of considerable controversy. The primary points of debate revolve around its effectiveness, safety, and cost. Continue reading
Will insurance cover Kisunla treatment?
Most insurance plans that cover treatments for early Alzheimer’s disease may cover Kisunla (donanemab‑azbt) if you meet certain rules set by the plan. These rules often include having early symptoms of Alzheimer’s disease and proof of amyloid plaque in the brain from a scan or spinal fluid test. Continue reading
How effective is Leqembi in delaying Alzheimer's disease?
Leqembi (lecanemab-irmb) is a prescription medicine that can slow — but not stop or reverse — Alzheimer's disease in its early stages. In an 18-month study, people taking Leqembi declined about 27% more slowly than people taking a placebo (a treatment with no active drug). In simple terms, it took them about 5.3 months longer to reach the same level of memory and thinking loss. Continue reading
What's the mechanism of action for Leqembi (lecanemab-irmb)?
Leqembi (lecanemab-irmb) is a targeted treatment for early Alzheimer's disease that works by removing harmful amyloid plaques from the brain. It can slow the progression of memory and thinking problems but does not cure Alzheimer's or restore lost memory. Treatment should begin only after amyloid beta plaques have been confirmed. Continue reading
Is Leqembi eligible for Medicare or insurance coverage?
Medicare Part B covers intravenous (IV) Leqembi for eligible patients who meet CMS requirements, but coverage for the newly approved Leqembi IQLIK has not yet been announced; however, Medicare may cover it. Your out-of-pocket costs depend on your Medicare coverage, such as traditional Medicare with Medigap or a Medicare Advantage plan. Continue reading

Related medicines

Before you take this medicine: the information on this page is general and may not cover your personal circumstances. Read the label supplied with your medicine and ask a pharmacist or doctor if you are unsure, especially if you are pregnant, breastfeeding, taking other medicines or managing a long-term condition.
General medicine information Consumer-friendly language

Content is provided for education and is not medical advice. See our medical disclaimer.